Advertisement
U.S. markets open in 2 hours 4 minutes
  • S&P Futures

    5,306.25
    -2.00 (-0.04%)
     
  • Dow Futures

    40,141.00
    -3.00 (-0.01%)
     
  • Nasdaq Futures

    18,493.50
    -10.25 (-0.06%)
     
  • Russell 2000 Futures

    2,139.50
    +1.10 (+0.05%)
     
  • Crude Oil

    82.46
    +1.11 (+1.36%)
     
  • Gold

    2,232.40
    +19.70 (+0.89%)
     
  • Silver

    24.75
    +0.00 (+0.01%)
     
  • EUR/USD

    1.0797
    -0.0033 (-0.30%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.98
    +0.20 (+1.56%)
     
  • GBP/USD

    1.2626
    -0.0012 (-0.09%)
     
  • USD/JPY

    151.3530
    +0.1070 (+0.07%)
     
  • Bitcoin USD

    70,764.52
    +649.82 (+0.93%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,956.51
    +24.53 (+0.31%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Sorrento Therapeutics appoints Amar Singh as Chief Business Officer

Sorrento Therapeutics (SRNE) appointed Amar Singh as Executive VP and Chief Business Officer. In this role, Mr. Singh will be responsible for overseeing Sorrento's partnering activities. Mr. Singh joins Sorrento from Synta Pharmaceuticals (SNTA), where he was a Senior VP and Chief Business Officer.

Advertisement